Michael F. Roman's Insider Trades & SAST Disclosures
Michael F. Roman's most recent trade in Abbott Laboratories was a trade of 1,635 Common shares without par value done . Disclosure was reported to the exchange on April 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael F. Roman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 1,635 | 8,478 (0%) | 0% | 0 | Common shares without par value | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 265 | 4,957 | - | - | Stock Equivalent Units | |
| Petco Health and Wellness ... | Michael F. Romanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,321,139 | 1,321,139 | - | 0 | Class A Common Stock | |
| Petco Health and Wellness ... | Michael F. Romanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 393,082 | 393,082 | - | - | Employee Stock Option (Right to Buy) | |
| Petco Health and Wellness ... | Michael F. Romanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 323,835 | 323,835 | - | - | Performance Stock Unit | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 21,026 | 201,997 (0%) | 0% | 0 | Common Stock | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Feb 2025 | 9,589 | 192,408 (0%) | 0% | 0 | Common Stock | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Feb 2025 | 8,600 | 193,397 (0%) | 0% | 0 | Common Stock | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 130.14 per share. | 29 Jan 2025 | 54,775 | 230,493 (0%) | 0% | 130.1 | 7,128,419 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2025 | 54,775 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.27 per share. | 29 Jan 2025 | 29,670 | 199,497 (0%) | 0% | 152.3 | 4,517,851 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.32 per share. | 29 Jan 2025 | 2,473 | 191,929 (0%) | 0% | 152.3 | 376,687 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.33 per share. | 29 Jan 2025 | 1,994 | 189,930 (0%) | 0% | 152.3 | 303,746 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.28 per share. | 29 Jan 2025 | 1,955 | 197,542 (0%) | 0% | 152.3 | 297,707 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.34 per share. | 29 Jan 2025 | 1,925 | 187,940 (0%) | 0% | 152.3 | 293,255 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.39 per share. | 29 Jan 2025 | 1,723 | 182,814 (0%) | 0% | 152.4 | 262,568 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.31 per share. | 29 Jan 2025 | 1,581 | 194,402 (0%) | 0% | 152.3 | 240,802 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.26 per share. | 29 Jan 2025 | 1,326 | 229,167 (0%) | 0% | 152.3 | 201,897 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.35 per share. | 29 Jan 2025 | 1,274 | 186,632 (0%) | 0% | 152.4 | 194,094 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.36 per share. | 29 Jan 2025 | 1,153 | 185,443 (0%) | 0% | 152.4 | 175,671 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.43 per share. | 29 Jan 2025 | 903 | 180,895 (0%) | 0% | 152.4 | 137,644 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.30 per share. | 29 Jan 2025 | 687 | 196,483 (0%) | 0% | 152.3 | 104,630 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.30 per share. | 29 Jan 2025 | 500 | 195,983 (0%) | 0% | 152.3 | 76,151 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.37 per share. | 29 Jan 2025 | 424 | 184,819 (0%) | 0% | 152.4 | 64,605 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.29 per share. | 29 Jan 2025 | 372 | 197,170 (0%) | 0% | 152.3 | 56,652 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.41 per share. | 29 Jan 2025 | 300 | 182,198 (0%) | 0% | 152.4 | 45,723 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.38 per share. | 29 Jan 2025 | 282 | 184,537 (0%) | 0% | 152.4 | 42,971 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.42 per share. | 29 Jan 2025 | 200 | 181,798 (0%) | 0% | 152.4 | 30,484 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.39 per share. | 29 Jan 2025 | 200 | 182,614 (0%) | 0% | 152.4 | 30,478 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.36 per share. | 29 Jan 2025 | 200 | 185,243 (0%) | 0% | 152.4 | 30,472 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.40 per share. | 29 Jan 2025 | 116 | 182,498 (0%) | 0% | 152.4 | 17,678 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.42 per share. | 29 Jan 2025 | 100 | 181,998 (0%) | 0% | 152.4 | 15,242 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.41 per share. | 29 Jan 2025 | 100 | 182,098 (0%) | 0% | 152.4 | 15,241 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.34 per share. | 29 Jan 2025 | 65 | 189,865 (0%) | 0% | 152.3 | 9,902 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.36 per share. | 29 Jan 2025 | 36 | 186,596 (0%) | 0% | 152.4 | 5,485 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.35 per share. | 29 Jan 2025 | 34 | 187,906 (0%) | 0% | 152.4 | 5,180 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 152.40 per share. | 29 Jan 2025 | 5 | 191,924 (0%) | 0% | 152.4 | 762 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.05 per share. | 24 Jan 2025 | 45,276 | 220,994 (0%) | 0% | 146.1 | 6,612,560 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 45,276 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 24 Jan 2025 | 25,403 | 195,591 (0%) | 0% | 150 | 3,810,450 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.04 per share. | 24 Jan 2025 | 9,100 | 176,923 (0%) | 0% | 150.0 | 1,365,319 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.01 per share. | 24 Jan 2025 | 8,321 | 187,170 (0%) | 0% | 150.0 | 1,248,233 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.02 per share. | 24 Jan 2025 | 947 | 186,223 (0%) | 0% | 150.0 | 142,069 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.04 per share. | 24 Jan 2025 | 558 | 176,365 (0%) | 0% | 150.0 | 83,722 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.06 per share. | 24 Jan 2025 | 445 | 175,720 (0%) | 0% | 150.1 | 66,777 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.02 per share. | 24 Jan 2025 | 200 | 186,023 (0%) | 0% | 150.0 | 30,005 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.01 per share. | 24 Jan 2025 | 100 | 195,491 (0%) | 0% | 150.0 | 15,001 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.05 per share. | 24 Jan 2025 | 100 | 176,265 (0%) | 0% | 150.1 | 15,005 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.05 per share. | 24 Jan 2025 | 100 | 176,165 (0%) | 0% | 150.1 | 15,005 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 24 Jan 2025 | 2 | 175,718 (0%) | 0% | 150 | 300 | Common Stock |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 311 | 4,670 | - | - | Stock Equivalent Units | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 309 | 4,338 | - | - | Stock Equivalent Units | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | 07 Aug 2024 | 4,139 | 175,571 (0%) | 0% | 123.5 | 510,960 | Common Stock | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | 07 Aug 2024 | 611 | 174,960 (0%) | 0% | 123.5 | 75,434 | Common Stock | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | 07 Aug 2024 | 482 | 174,035 (0%) | 0% | 123.5 | 59,517 | Common Stock | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | 07 Aug 2024 | 443 | 174,517 (0%) | 0% | 123.5 | 54,697 | Common Stock | |
| Five Below Inc | Michael F. Romanko | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 17,137 | 32,412 (0%) | 0% | 0 | Common Stock | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 339 | 4,009 | - | - | Stock Equivalent Units | |
| Five Below Inc | Michael F. Romanko | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 534 | 15,275 (0%) | 0% | 0 | Common Stock | |
| 3M Co. | Michael F. Roman | Director, Chairman of the Board | 03 May 2024 | 316,644 | 316,644 | - | - | Non-qualified Stock Option (Right to Buy) | ||
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 1,866 | 6,843 (0%) | 0% | 0 | Common shares without par value | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 310 | 3,650 | - | - | Stock Equivalent Units | |
| Five Below Inc | Michael F. Romanko | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 3,535 | 13,691 (0%) | 0% | 0 | Common Stock | |
| Five Below Inc | Michael F. Romanko | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 2,221 | 15,912 (0%) | 0% | 0 | Common Stock | |
| Five Below Inc | Michael F. Romanko | CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 176.79 per share. | 21 Mar 2024 | 1,171 | 14,741 (0%) | 0% | 176.8 | 207,021 | Common Stock |
| Five Below Inc | Michael F. Romanko | CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 206.96 per share. | 07 Mar 2024 | 823 | 10,442 (0%) | 0% | 207.0 | 170,328 | Common Stock |
| Five Below Inc | Michael F. Romanko | CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 204.82 per share. | 07 Mar 2024 | 286 | 10,156 (0%) | 0% | 204.8 | 58,579 | Common Stock |
| 3M Co. | F. Michael Roman | Director, Chairman and CEO | 05 Feb 2024 | 791 | 157,520 (0%) | 0% | 0 | Common Stock | ||
| Abbott Laboratories | Roman Michael F. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 320 | 3,324 | - | - | Stock Equivalent Units | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 363 | 2,988 | - | - | Stock Equivalent Units | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 316 | 2,612 | - | - | Stock Equivalent Units | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 1,816 | 4,977 (0%) | 0% | 0 | Common shares without par value | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 325 | 2,285 | - | - | Stock Equivalent Units | |
| Five Below Inc | Michael F. Romanko | CMO | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 27 Mar 2023 | 8,110 | 11,265 (0%) | 0% | 200 | 1,622,000 | Common Stock |
| Five Below Inc | Michael F. Romanko | CMO | Sale of securities on an exchange or to another person at price $ 201.45 per share. | 27 Mar 2023 | 1,564 | 19,375 (0%) | 0% | 201.5 | 315,068 | Common Stock |
| Five Below Inc | Michael F. Romanko | CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 195.33 per share. | 16 Mar 2023 | 120 | 20,939 (0%) | 0% | 195.3 | 23,440 | Common Stock |
| Five Below Inc | Michael F. Romanko | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 3,112 | 20,809 (0%) | 0% | 0 | Common Stock | |
| Five Below Inc | Michael F. Romanko | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 822 | 21,631 (0%) | 0% | 0 | Common Stock | |
| Five Below Inc | Michael F. Romanko | CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 199.53 per share. | 08 Mar 2023 | 572 | 21,059 (0%) | 0% | 199.5 | 114,131 | Common Stock |
| 3M Co. | Michael F. Roman | Director, Chairman and CEO | 06 Feb 2023 | 1,140 | 126,845 (0%) | 0% | 0 | Common Stock | ||
| Five Below Inc | Michael F. Romanko | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 8,796 | 17,697 (0%) | 0% | 0 | Common Stock | |
| Five Below Inc | Michael F. Romanko | CMO | Sale of securities on an exchange or to another person at price $ 191.50 per share. | 11 Jan 2023 | 3,750 | 8,901 (0%) | 0% | 191.5 | 718,138 | Common Stock |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 300 | 1,949 | - | - | Stock Equivalent Units | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 341 | 1,641 | - | - | Stock Equivalent Units | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 303 | 1,295 | - | - | Stock Equivalent Units | |
| 3M Co. | Michael F. Roman | Director, Chairman and CEO | 03 May 2022 | 10,610 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | ||
| 3M Co. | Michael F. Roman | Director, Chairman and CEO | 03 May 2022 | 10,610 | 90,360 (0%) | 0% | 146.2 | 1,551,288 | Common Stock | |
| 3M Co. | Michael F. Roman | Director, Chairman and CEO | 03 May 2022 | 10,610 | 100,970 (0%) | 0% | 101.5 | 1,076,809 | Common Stock | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 1,602 | 3,101 (0%) | 0% | 0 | Common shares without par value | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 278 | 987 | - | - | Stock Equivalent Units | |
| 3M Co. | Michael F. Roman | Director, Chairman and CEO | 07 Feb 2022 | 754 | 89,608 (0%) | 0% | 0 | Common Stock | ||
| 3M Co. | Michael F. Roman | Director, Chairman and CEO | 31 Dec 2021 | 1,290 | 66,860 (0%) | 0% | 0 | Common Stock | ||
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 279 | 469 | - | - | Stock Equivalent Units | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 189 | 189 | - | - | Stock Equivalent Units | |
| 3M Co. | Michael F. Roman | Director, Chairman and CEO | 03 May 2021 | 9,747 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | ||
| 3M Co. | Michael F. Roman | Director, Chairman and CEO | 03 May 2021 | 9,747 | 73,917 (0%) | 0% | 87.9 | 856,664 | Common Stock | |
| 3M Co. | Michael F. Roman | Director, Chairman and CEO | 03 May 2021 | 6,803 | 67,114 (0%) | 0% | 197.8 | 1,345,599 | Common Stock | |
| Abbott Laboratories | Michael F. Roman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2021 | 1,499 | 1,499 (0%) | 0% | 0 | Common shares without par value | |
| 3M Co. | Michael F. Roman | Director, Chairman and CEO | 01 Feb 2021 | 463 | 63,734 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges